Potential COVID-19 drug poses retinal toxicity risk The Australian Therapeutic Goods Administration (TGA) has warned that an autoimmune and malaria drug being investigated as a potential treatment for COVID-19 can cause permanent retinal damage. Read More Myles HumeApril 8, 2020, 8:32 amApril 8, 2020
